Congress:
ECR24
Poster Number:
C-20089
Type:
EPOS Radiologist (scientific)
DOI:
10.26044/ecr2024/C-20089
Authorblock:
O. Y. Panina, A. Gromov, Y. Vasilev, K. Akhmad, D. Semenov; Москва/RU
Disclosures:
Olga Yurevna Panina:
Nothing to disclose
Alexander Gromov:
Nothing to disclose
Yurii Vasilev:
Nothing to disclose
Kate Akhmad:
Nothing to disclose
Dmitry Semenov:
Nothing to disclose
Keywords:
Abdomen, Liver, Oncology, Experimental, MR, Chemotherapy, Imaging sequences, Technical aspects, Cancer, Drugs / Reactions, Quality assurance
The data of standard liver CT and MRI of 25 patients were obtained. MRI was performed on a 3 T scanner, Siemens Skyra. Inclusion criteria: patients with signs of stethohepatosis on the background of antitumor treatment, as well as the absence before antitumor therapy of signs of steatosis, hemochromatosis according to CT data both based on indicators of liver density HU, and anamnestic data. The set values of the FF were determined based on the results of preliminary phantom testing of the MR tomograph. The liver FF was measured using two formulas based on the signal characteristics of the Dixon sequences: FF1= (In-Out)/2*In*100%; FF2= Fat/(Fat+water)*100%.